Buscar
Mostrando ítems 1-10 de 1255
Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis
(World Health Organization, 2020)
Anticlastogenic activity of aqueous extract of Agaricus blazei in drug-metabolizing cells (HTCs) during cell cycle
(Taylor & Francis Inc, 2007-03-01)
The mushroom Agaricus blazei has been extensively investigated because of evidence of its antimutagenic, antitumor, and anticarcinogenic activities. This study investigated the clastogenic and/or anticlastogenic activity ...
Anticlastogenic activity of aqueous extract of Agaricus blazei in drug-metabolizing cells (HTCs) during cell cycle
(Taylor & Francis Inc, 2007-03-01)
The mushroom Agaricus blazei has been extensively investigated because of evidence of its antimutagenic, antitumor, and anticarcinogenic activities. This study investigated the clastogenic and/or anticlastogenic activity ...
Anticlastogenic activity of aqueous extract of Agaricus blazei in drug-metabolizing cells (HTCs) during cell cycle
(Taylor & Francis Inc, 2014)
Direct-acting antiviral agents for HCV-associated glomerular disease and the current evidence
(Molecular Diversity Preservation International, 2019-10)
Glomerular disease is an extra-hepatic manifestation of hepatitis C virus infection (HCV) and membranoproliferative glomerulonephritis is the most frequent glomerular disease associated with HCV. It occurs commonly in ...
Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz, 2017)
Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis
(World Health Organization, 2020)